IFP Advisors’s Citius Oncology CTOR Stock Holding History

IFP Advisors’s Portfolio CTOR Stock Details CTOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$108K	Hold	107,424	–	–	﹤0.01%	1917
2026 Q2	$69.8K	Hold	107,424	–	–	﹤0.01%	2195
2026 Q1	$66.6K	Buy	107,424 +20,000	+23%	+$20.1K	﹤0.01%	2093
2025 Q4	$87.4K	Buy	87,424 +54,209	+163%	+$77.8K	﹤0.01%	1878
2025 Q3	$67.4K	Buy	33,215 +11,000	+50%	+$23.8K	﹤0.01%	1920
2025 Q2	$96.6K	Hold	22,215	–	–	﹤0.01%	1656
2025 Q1	$20.7K	Hold	22,215	–	–	﹤0.01%	2276
2024 Q4	$25.5K	Buy	22,215 +14,080	+173%	+$15.8K	﹤0.01%	2133
2024 Q3	$11.3K	Buy	+8,135	New	+$57.7K	﹤0.01%	2376

Other funds holding CTOR

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Private Advisor Group Morristown, New Jersey $29.9B AUM 19.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

IFP Advisors's CTOR Position: Q3 2026 in Review

IFP Advisors held its Citius Oncology (CTOR) position steady in Q3 2026 at 107,424 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #1917.

IFP Advisors first reported a position in CTOR in Q3 2024 and has held it in 9 quarters since. 7 funds tracked by Wall St. Rank hold CTOR as of Q3 2026.

IFP Advisors held 107,424 shares of Citius Oncology worth $108K as of Q3 2026.
IFP Advisors left its Citius Oncology share count unchanged in Q3 2026.
Citius Oncology made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #1917 holding.
IFP Advisors first reported a position in Citius Oncology in Q3 2024 and has held it in 9 quarters since.
7 funds tracked by Wall St. Rank held Citius Oncology as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.